Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04528121
What this trial is testing

Effect of CoDuSe Balance Training and Step Square Exercises on Risk of Fall in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Lama Saad El-Din Mahmoud 52
Large-scale testing (Phase 3)Ended earlyNCT05265728
What this trial is testing

Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 21
Large-scale testing (Phase 3)Ended earlyNCT04032171
What this trial is testing

Study of Evobrutinib in Participants With RMS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 1
Not applicableUnknownNCT00331747
What this trial is testing

Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate

Who this might be right for
Multiple Sclerosis
Sheba Medical Center 20
Large-scale testing (Phase 3)Ended earlyNCT02881567
What this trial is testing

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Biogen 41
Not applicableStudy completedNCT07264725
What this trial is testing

Libyan Multiple Sclerosis Registry Study

Who this might be right for
Multiple Sclerosis
University of Zintan 369
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Post-approval studies (Phase 4)WithdrawnNCT02472938
What this trial is testing

Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen
Large-scale testing (Phase 3)Study completedNCT04121221
What this trial is testing

Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Mapi Pharma Ltd. 1,016
Testing effectiveness (Phase 2)Ended earlyNCT02975349
What this trial is testing

Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 267
Testing effectiveness (Phase 2)Temporarily pausedNCT04909502
What this trial is testing

Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Emerald Health Pharmaceuticals 50
Large-scale testing (Phase 3)Study completedNCT04115488
What this trial is testing

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Polpharma Biologics S.A. 265
Not applicableUnknownNCT04157283
What this trial is testing

Sexual Dysfunction in Patients With Relapsing Remitting Multiple Sclerosis and Associated Comorbidities

Who this might be right for
Multiple SclerosisSexual Dysfunction
Mansoura University Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00203073
What this trial is testing

Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 40
Very early researchStudy completedNCT05080270
What this trial is testing

Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
FibroBiologics 5
Not applicableStudy completedNCT06395909
What this trial is testing

Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis+1 more
Novartis 113
Testing effectiveness (Phase 2)Study completedNCT02040298
What this trial is testing

Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of California, San Francisco 50
Testing effectiveness (Phase 2)Ended earlyNCT01963611
What this trial is testing

Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
EMD Serono 255
Post-approval studies (Phase 4)Study completedNCT00534261
What this trial is testing

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 284
Very early researchUnknownNCT01453868
What this trial is testing

The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Nelson Mandela Metropolitan University 60
Next Page